Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 39.08
+1.40 (3.72%)
Nov 10, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 7.63 billion as of November 9, 2026. It is the 10,359th most valuable company in the world and the 507th biggest in Hong Kong. Its market cap has decreased by 34.41% in one year.
Market Cap
7.63B
Enterprise Value
6.62B
Revenue
246.16M
Global Rank
Country Rank
#507 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 7.63B, a decrease of -41.23%. That is a compound annual growth rate of -33.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 7.63B | -24.83% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 9.50B |
| Duality Biotherapeutics | 9.50B |
| HBM Holdings | 8.57B |
| CStone Pharmaceuticals | 8.51B |
| GenFleet Therapeutics (Shanghai) | 8.07B |
| Suzhou Ribo Life Science | 7.33B |
| Shanghai Haohai Biological Technology | 7.26B |
| Shaanxi Micot Pharmaceutical Technology | 6.24B |